Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Data on cancer vaccines described by researchers at Johns Hopkins University, Department of Pathology
April 14th, 2009
Investigators publish new data in the report 'Low-dose radiation enhances therapeutic HPV DNA vaccination in tumor-bearing hosts.' "Current therapeutic approaches to treatment of patients with bulky cervical cancer are based on conventional in situ ablative modalities including cisplatin-based chemotherapy and radiation therapy. The 5-year survival of patients with nonresectable disease is dismal," scientists in the United States report. "Because over 99% of squamous cervical cancer is caused by persistent infection with an oncogenic strain of human papillomavirus (HPV), particularly type 16 and viral oncoproteins E6 and E7 are functionally required for disease...
Source: Cancer Weekly (2009-04-14)
|
